NCT05443906 is a NA clinical trial of Home exercise in Neurodegenerative Diseases, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc..

Who is sponsoring NCT05443906?

NCT05443906 is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc..

What drugs are being tested in NCT05443906?

Interventions in NCT05443906: Home exercise.

What condition does NCT05443906 study?

NCT05443906 studies Neurodegenerative Diseases, Leukodystrophy, Ataxia, LBSL, Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Cerebellar Ataxia, Adrenomyeloneuropathy.

Is NCT05443906 still recruiting?

NCT05443906 is currently recruiting now. Last updated 10 March 2025.

Last reviewed 2025-03-10 · How we verify

NCT05443906

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home Exercise for Individuals with Neurodegenerative Disease

Recruiting now NA Last updated 10 March 2025

What this trial tests

NA trial testing Home exercise in Neurodegenerative Diseases in 30 participants. Currently enrolling.

Timeline

13 February 2023

Primary endpoint
30 July 2026

30 July 2027

Quick facts

Lead sponsor	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	13 February 2023
Primary completion	30 July 2026
Estimated completion	30 July 2027
Sites	1 location across United States

Drugs / interventions tested

Home exercise

Conditions studied

Neurodegenerative Diseases — all drugs for Neurodegenerative Diseases →
Leukodystrophy — all drugs for Leukodystrophy →
Ataxia — all drugs for Ataxia →
LBSL — all drugs for LBSL →

Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Who can join

Adults 5 to 75, any sex, with Neurodegenerative Diseases or Leukodystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Home exercise

Trials testing the same drug.

NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
NCT07327008 — The Effectiveness of Telerehabilitation in Liver Transplant Patients · NA · not yet recruiting
NCT07034417 — The Effectiveness Of BETY In Fibromyalgia · NA · not yet recruiting
NCT06977321 — Effectiveness of Kinesiotaping and Peloidotherapy in Carpal Tunnel Syndrome · NA · recruiting
NCT06654206 — Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients · EARLY_PHASE1 · not yet recruiting

Other recruiting trials for Neurodegenerative Diseases

Currently open trials in the same condition.

NCT07324330 — Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity · NA · recruiting
NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
NCT07514520 — Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION · active not recruiting
NCT06755840 — Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study · recruiting
NCT06596746 — Neurodegenerative Diseases Progression Markers (MARKERS-NDD) · recruiting

Other Hugo W. Moser Research Institute at Kennedy Krieger, Inc. trials

Trials by the same sponsor.

NCT07221968 — Melatonin for the Treatment of DEE-SWAS · Phase 2 · not yet recruiting
NCT07061470 — A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep · Phase 1, PHASE2 · not yet recruiting
NCT06915480 — Reducing Missed Appointments · Phase 3 · recruiting
NCT07278388 — Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 · NA · recruiting
NCT06810180 — Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Het · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05443906 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Last refreshed: 10 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05443906.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing